PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers unlock how key drug kills tropical parasites

Discovery could lead to new treatments for filarial diseases

Researchers unlock how key drug kills tropical parasites
2010-11-11
(Press-News.org) EAST LANSING, Mich. — In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.

Understanding how the drug ivermectin works has the potential to lead to new treatments for the diseases, in which the body is infected with parasitic worms, said Charles Mackenzie, a professor of veterinary pathology in the College of Veterinary Medicine and researcher on the project. The diseases afflict about 140 million people worldwide, doing much of their damage in equatorial Africa.

"Ivermectin is one of the most important veterinary and human anti-parasitic agents ever," Mackenzie said. "Knowing specifically how it interacts with the body's own immune system and kills parasitic worms opens up whole new treatment avenues."

The research appears in the current edition of the Proceedings of the National Academy of Sciences.

Elephantiasis (lymphatic filariasis) is caused by tiny worms spread via mosquitoes and results in severe swelling of the legs, arms and torso. River blindness (onchocerciasis) is spread by black flies, and after the worms die in a person's eye, they can cause blindness and debilitating skin disease.

Ivermectin works by killing the first stage of the worm in the human body, and also appears to paralyze the reproductive tract of the adult female worms, stopping reproduction of new parasites.

What the researchers discovered is that the drug does this by preventing the worm from secreting proteins through a pore in its mid-body; ivermectin binds to receptors at the pore and blocks the secretions. It is the secretions that normally block a person's ability to attack and kill the worm; after the drug prevents them, the host's own immune system is able to attack and kill the parasites.

"Understanding how the worms were avoiding the host's immune responses will greatly enhance our ability to manipulate the immune system to the advantage of the host, and perhaps develop vaccines," Mackenzie said. "Also, one of the most important challenges in the overall effort against filarial infections relates to the development of resistance and the loss of efficacy of the drugs we use; this new knowledge provides an important key to understanding and perhaps preventing resistance."

Ivermectin was developed by pharmaceutical firm Merck & Co. in the 1970s from a soil fungus. It was donated in 1987 for use to treat river blindness, as existing drugs were in fact inducing blindness. Ivermectin was able to be used safely in mass drug administration programs in many developing countries, shifting the paradigm for how public health programs delivered medicines in rural areas. The drug then was used in other parasitic disease programs, such as the one for elephantiasis, treating more than 100 million people for that disease.

Mackenzie has worked for more than 20 years on tropical filarial diseases, much of that time partnering with Tim Geary at McGill University in Montreal. Geary's lab was critical in the ivermectin findings, as was McGill graduate student Yovany Moreno. Geary and Mackenzie also recently were awarded $2 million from the Gates Foundation to study another anti-filarial drug, flubendazole.



INFORMATION:

Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.


[Attachments] See images for this press release:
Researchers unlock how key drug kills tropical parasites

ELSE PRESS RELEASES FROM THIS DATE:

Potential hemlock hybrids tolerant to invasive hemlock woolly adelgid

2010-11-11
New hemlock hybrids that are tolerant to the invasive insect known as hemlock woolly adelgid have been created by U.S. Department of Agriculture (USDA) scientists. Geneticist Richard Olsen and horticulturist Sue Bentz of USDA's Agricultural Research Service (ARS) teamed up with Forest Service entomologist Mike Montgomery to breed and select these tolerant hybrids. Olsen and Bentz work in the U.S. National Arboretum's Floral and Nursery Plants Research Unit in Beltsville, Md. The arboretum is located in Washington, D.C., and is operated by ARS, the principal intramural ...

By reducing disease risk, 'Desktop Medicine' will transform the practice of medicine

2010-11-11
Gone are the days when a doctor's only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called "Desktop Medicine" is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association. "Desktop medicine," a model defined by Jason Karlawish, MD, Associate Professor ...

Bowel cancer: 8 years of colonoscopy screening in Germany -- a success story

2010-11-11
By the end of this year, colonoscopy screening will have prevented bowel cancer in approximately 99 000 people since it was introduced in Germany. This is the result obtained by Hermann Brenner of the German Cancer Research Center in Heidelberg and his co-authors in their interim assessment conducted eight years after the procedure was added to the German cancer screening program. The authors present their projection and initial results of colonoscopy screening in Germany in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010: 107(43): 753 ...

Updated NIST software uses combination testing to catch bugs fast and easy

Updated NIST software uses combination testing to catch bugs fast and easy
2010-11-11
Researchers at the National Institute of Standards and Technology (NIST) have released an updated version of a computer system testing tool that can cut costs by more efficiently finding flaws. A tutorial on using the tool accompanies the new release. Catching software "bugs" before a program is released enhances computer security because hackers often exploit these flaws to introduce malware, including viruses, to disrupt or take control of computer systems. But it's difficult. A widely cited 2002 study prepared for NIST* reported that even though 50 percent of software ...

U of M researchers find learning in the visual brain

2010-11-11
A team of researchers from the University of Minnesota's College of Liberal Arts and College of Science and Engineering have found that an early part of the brain's visual system rewires itself when people are trained to perceive patterns, and have shown for the first time that this neural learning appears to be independent of higher order conscious visual processing. The researchers' findings could help shape training programs for people who must learn to detect subtle patterns quickly, such as doctors reading X-rays or air traffic controllers monitoring radars. In addition, ...

New NIST dietary supplement reference materials could be 'berry' useful

New NIST dietary supplement reference materials could be berry useful
2010-11-11
National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries—cranberries, blueberries and bilberries. As described in a recent paper,* manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools. berry SRMs Dietary supplement manufacturers often include health claims on products made with Vaccinium berries. Suggested benefits include prevention of urinary tract ...

Academies of science call for amendments to impracticable Genetic Diagnostics Act

2010-11-11
Many aspects of the German Genetic Diagnostics Act (Gendiagnostikgesetz) are out of touch with the latest technology, almost impossible to implement in clinical practice, or even detrimental to the success of recognised screening tests, such as newborn screening. The Act, which came into force in February 2010, is in desperate need of amendment. This was the conclusion reached by the Academy Workgroup "Predictive genetic diagnostics as an instrument of disease prevention" of the German Academy of Sciences Leopoldina, the Berlin-Brandenburg Academy of Sciences and Humanities ...

NIST pings key material in sonar, closes gap on structural mystery

2010-11-11
Using a neutron beam as a probe, researchers working at the National Institute of Standards and Technology (NIST) have begun to reveal the crystal structure of a compound essential to technologies ranging from sonar to computer memory. Their recent work* provides long-sought insight into just how a widely used material of modern technology actually works. The compound is a "piezoelectric," a material capable of changing one kind of energy into another—mechanical to electrical, or vice versa. Long employed in sonar systems to detect sound waves, more recently piezoelectrics ...

Looking for wireless? Try a local farm

Looking for wireless? Try a local farm
2010-11-11
VIDEO: Wireless. For most, the word conjures images quaint coffee shops or busy airport lobbies -- places where people drop in to check on business or check in with other people. But... Click here for more information. BEAUMONT – Wireless. For most, the word conjures images quaint coffee shops or busy airport lobbies – places where people drop in to check on business or check in with other people. But increasingly "wireless" is showing up on the farm to help produce better ...

AFM positioning: Shining light on a needle in a haystack

AFM positioning: Shining light on a needle in a haystack
2010-11-11
The researchers characterize their new technique as a neat solution to the "needle in a haystack" problem of nanoscale microscopy, but it's more like the difference between finding the coffee table in a darkened room either by walking around until you fall over it, or using a flashlight. In a new paper,* a group from JILA—a joint venture of the National Institute of Standards and Technology (NIST) and the University of Colorado—finds tiny assemblies of biomolecules for subsequent detailed imaging by combining precision laser optics with atomic force microscopy. The ...

LAST 30 PRESS RELEASES:

Osteoporosis treatment benefits people older than 80

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Thyroid treatment may improve gut health in people with hypothyroidism

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

High blood sugar may have a negative impact on men’s sexual health

Emotional health of parents tied to well-being of children with growth hormone deficiency

Oxytocin may reduce mood changes in women with disrupted sleep

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

[Press-News.org] Researchers unlock how key drug kills tropical parasites
Discovery could lead to new treatments for filarial diseases